31 May 2023
Merck Increases Global Commitment to Biosafety Testing With 35 Million Euro Investment in Scotland
Press release here:
Read storyMembers' News
24 Apr 2023
Medannex awarded Innovation Passport
Edinburgh, 24 April 2023
Read story19 Apr 2023
30 Technology Antimicrobial Nitric Oxide Platform Acquired by Convatec Group
30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications
Read story3 Apr 2023
Sistemic Mycoplasma Detections Service
Read story
31 Mar 2023
UK Government joined the CPTPP
The UK Government has joined the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP).
Read story30 Mar 2023
RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License
RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License for their cGMP Manufacturing facilities in Edinburgh, UK
Read story10 Mar 2023
Calcivis targets US expansion after securing FDA PMA approval
Calcivis targets US expansion after securing FDA PMA approval
Read story2 Mar 2023
Merck Livingston announces 15 new jobs and 2.6 million stg investment
Merck Livingston announces 15 new jobs and £2.6 million investment
Read story1 Mar 2023
Medannex receives Orphan Designation from the European Medicines Agency for Pancreatic Cancer
Read story
1 Feb 2023
Firefinch Software announces partnership with i4 Product Design
Firefinch Software and i4 Product Design (i4PD) have announced that they have entered into a strategic partnership that will bring together the market leading software expertise of Firefinch Software with the hardware p…
Read story18 Jan 2023
Blackford announces acquisition by Bayer
Blackford announces acquisition by Bayer, the global life science company.
Read story14 Nov 2022
TauRx Announces Additional Investment of USD119 million
TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results
Read story6 Oct 2022
TauRx Announces Results from Phase 3 Alzheimer's Disease Study, LUCIDITY, Assuring Path for Regulato
TauRx Announces Results from Phase 3 Alzheimer’s Disease Study, LUCIDITY, Assuring Path for Regulatory Submissions
Read story1 Oct 2022
Cytomos GBP1.6 million additional funding secured
This £1.6m funding – led by Archangels, alongside Scottish Enterprise and Old College Capital – will enable the development and qualification of Cytomos Dielectric Spectroscopy (CDSTM) to move forward at pace and addres…
Read story13 Sep 2022
Lykan Bioscience and RoslinCT Announce the Establishment of a Scientific Advisory Board
HOPKINTON, MA and EDINBURGH, UK September 13, 2022 - Lykan Bioscience and RoslinCT, a leader in Contract Development and Manufacturing for cell therapies, announced the formation of its inaugural Scientific Advisory Boa…
Read story